Legal Representation
Attorney
Andrea M. Porterfield
USPTO Deadlines
Next Deadline
861 days remaining
Section 8 Declaration Due (Supplemental Register) (Based on registration date 20220524)
Due Date
May 24, 2028
Grace Period Ends
November 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 7, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 7, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 7, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 24, 2022 | NRCS | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 24, 2022 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
| Apr 6, 2022 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 5, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 1, 2022 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
| Mar 29, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 28, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 28, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 4, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 4, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 4, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 4, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 4, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 4, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 30, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 12, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Human cells, tissues, and cellular and tissue-based products, namely, umbilical cord tissue and placental tissue for commercial, scientific, and medical research use
First Use Anywhere:
20201100
First Use in Commerce:
20201100
Class 042
Research and development in the field of life sciences
First Use Anywhere:
20201100
First Use in Commerce:
20201100
Classification
International Classes
001
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"LABS"